Skip to main content

Niktimvo (axatilimab-csfr) closer to home

Receiving Niktimvo closer to home

Some patients may be able to receive Niktimvo at an alternate infusion site, sometimes closer to home.

Your doctor can help determine which setting is appropriate for your treatment.

Niktimvo is available at the following infusion locations:

icon of an infusion center

Bone marrow transplant center

  • Niktimvo infusions may be given at the same location where you received your bone marrow transplant. Your doctor can help determine if continuing treatment there is appropriate for your care
  • May be an option for people who need additional monitoring or support while receiving treatment
icon of an infusion suite

Local infusion center or suite

  • Infusion centers and suites are settings dedicated to infusions and can be freestanding clinics or part of hospitals or doctors' offices
  • May be an option for people whose care team identifies an appropriate local infusion setting
icon of a home

Your home

  • A highly skilled infusion provider will administer treatment in your home
  • May be an option for people who don't need additional monitoring or support during treatment. Your doctor will determine whether at-home infusions are appropriate for you
information icon

Please work with your primary healthcare provider to determine whether one of these options is right for you.

While Incyte has attempted to provide a complete listing of sites that are qualified to offer Niktimvo infusions, this list may not be complete and some provider statuses may have changed. Incyte does not endorse, recommend, or guarantee the quality of care for any healthcare provider. Nor does Incyte guarantee that the information on this site is current.

Please contact the site directly to get the most up-to-date information.

Ask about receiving Niktimvo closer to home

IncyteCARES may be able to support eligible patients by:

  • icon of circle with a check mark

    Educating your care team on alternate infusion location options

  • icon of circle with a check mark

    Helping you and your care team navigate insurance coverage,
    prior authorization, and treatment-related support

Added support for getting started

If you and your doctor decide that flexible infusion location options are right for you, your doctor can help guide you through the next steps, including working with you to complete the enrollment form and sending it to Incyte.

Talk to your doctor about enrolling in IncyteCARES

For guidance on how to start the conversation, check out the Niktimvo Closer to Home Discussion Guide


Frequently Asked Questions

You may be able to receive your infusion at your bone marrow transplant center, a local infusion center or suite, or your home. Talk with your doctor about enrolling in IncyteCARES for help finding infusion providers in your area that meet your needs.

The first step is talking with your doctor. It's important they understand your needs. Your doctor will need to enroll you in IncyteCARES. They can also help answer any questions you have about exploring infusion locations near you.

You may be able to move to local or in-home infusions once you have started your treatment with Niktimvo. Use the discussion guide here to talk with your doctor about whether a change in infusion site is right for you.

If you and your doctor agree that local or at-home infusions are appropriate for your treatment, you can use the infusion site locator on this page. Browse the map to locate infusion providers in your area that may be suitable for your treatment.

With at-home infusions, your treatment is administered by a highly skilled infusion provider in your home or other non-hospital setting.

Infusion suites are dedicated healthcare facilities that are run by an infusion pharmacy. Care is provided by registered nurses and pharmacists with special training in administering infusion medications. Suite-based infusions are an option for people who may prefer receiving their medication in a clinic setting.

Both options help reduce time spent traveling to receive infusion treatments.

Yes, many home infusion providers are specially trained and experienced in administering infusion therapies, including treatments for cancer.

When preparing to get infusions at home, it's important to have a dedicated space ready. Choose a spot that is clean and well lit and where you'll feel comfortable during your infusion. Keep a book, music player, phone, or television nearby to help pass the time during your infusion.

Talk with your doctor if you have any other questions about how to prepare for receiving Niktimvo infusions at home. For more information, you can call IncyteCARES at 1-855-452-5234, Monday through Friday, 8 AM–8 PM ET, or visit www.incytecares.com/oncology-hematology-niktimvo/.

Yes, IncyteCARES is a patient support program that will help you during your treatment with Niktimvo. Once your doctor enrolls you in IncyteCARES, you will receive a phone call from a representative who can help you understand your insurance coverage and financial assistance options. Your IncyteCARES representative can also offer helpful resources, including information on receiving Niktimvo closer to home.

See how IncyteCARES may help

Find helpful Niktimvo resources

Indications and Usage

NiktimvoTM (axatilimab-csfr) is a prescription medicine used to treat adults and children who weigh at least 88.2 pounds (40 kg) with chronic graft-versus-host disease (cGVHD) after receiving at least 2 prior treatments (systemic therapy) and they did not work.

It is not known if Niktimvo is safe and effective in adults and children weighing less than 88.2 pounds (40 kg).

IMPORTANT SAFETY INFORMATION

What are the possible side effects of Niktimvo?

Niktimvo may cause serious side effects, including:

Infusion-related reactions. Infusion-related reactions are common with Niktimvo and can be serious. Your healthcare provider will monitor you for infusion-related reactions during your treatment. If you have a reaction, your healthcare provider may temporarily or completely stop your treatment with Niktimvo. Tell your healthcare provider right away if you have fever, chills, rash, flushing, shortness of breath, trouble breathing, nausea, vomiting, or symptoms of high blood pressure such as chest pain, headaches, or blurred vision during an infusion of Niktimvo.

The most common side effects of Niktimvo include:

  • infections
  • increased blood level of liver enzymes
  • decreased blood level of phosphate
  • low red blood cell count (anemia)
  • muscle, bone, or joint pain
  • increased blood level of pancreatic enzymes
  • low energy
  • increased blood level of calcium
  • increased blood level of a muscle enzyme
  • increased blood level of a bone enzyme
  • nausea
  • headache
  • diarrhea
  • cough
  • fever
  • shortness of breath

These are not all the possible side effects of Niktimvo. Call your doctor for medical advice about side effects.

Before receiving Niktimvo, tell your healthcare provider about all of your medical conditions, including if you:

  • have or have had liver problems.
  • are pregnant or plan to become pregnant. Niktimvo may harm your unborn baby.

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with Niktimvo.
    • You should use an effective method of birth control during your treatment and for 30 days after your last dose of Niktimvo. Talk to your healthcare provider about birth control methods that you can use during this time.
    • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Niktimvo.
  • are breastfeeding or plan to breastfeed. It is not known if Niktimvo passes into your breast milk. Do not breastfeed during treatment and for 30 days after your last dose of Niktimvo.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Niktimvo.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.

Expand
Collapse

Indications and Usage

NiktimvoTM (axatilimab-csfr) is a prescription medicine used to treat adults and children who weigh at least 88.2 pounds (40 kg) with chronic graft-versus-host disease (cGVHD) after receiving at least 2 prior treatments (systemic therapy) and they did not work.

It is not known if Niktimvo is safe and effective in adults and children weighing less than 88.2 pounds (40 kg).

IMPORTANT SAFETY INFORMATION

What are the possible side effects of Niktimvo?

Niktimvo may cause serious side effects, including:

Infusion-related reactions. Infusion-related reactions are common with Niktimvo and can be serious. Your healthcare provider will monitor you for infusion-related reactions during your treatment. If you have a reaction, your healthcare provider may temporarily or completely stop your treatment with Niktimvo. Tell your healthcare provider right away if you have fever, chills, rash, flushing, shortness of breath, trouble breathing, nausea, vomiting, or symptoms of high blood pressure such as chest pain, headaches, or blurred vision during an infusion of Niktimvo.

The most common side effects of Niktimvo include:

  • infections
  • increased blood level of liver enzymes
  • decreased blood level of phosphate
  • low red blood cell count (anemia)
  • muscle, bone, or joint pain
  • increased blood level of pancreatic enzymes
  • low energy
  • increased blood level of calcium
  • increased blood level of a muscle enzyme
  • increased blood level of a bone enzyme
  • nausea
  • headache
  • diarrhea
  • cough
  • fever
  • shortness of breath

These are not all the possible side effects of Niktimvo. Call your doctor for medical advice about side effects.

Before receiving Niktimvo, tell your healthcare provider about all of your medical conditions, including if you:

  • have or have had liver problems.
  • are pregnant or plan to become pregnant. Niktimvo may harm your unborn baby.

    Females who are able to become pregnant:

    • Your healthcare provider should do a pregnancy test before you start treatment with Niktimvo.
    • You should use an effective method of birth control during your treatment and for 30 days after your last dose of Niktimvo. Talk to your healthcare provider about birth control methods that you can use during this time.
    • Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Niktimvo.
  • are breastfeeding or plan to breastfeed. It is not known if Niktimvo passes into your breast milk. Do not breastfeed during treatment and for 30 days after your last dose of Niktimvo.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Please see the Full Prescribing Information, which includes a more complete discussion of the risks associated with Niktimvo.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

You may also report side effects to Incyte Medical Information at 1-855-463-3463.